Anna M. Detert brings 25+ years of experience in life sciences, spanning biopharma, diagnostics, venture capital, and private equity. She was most recently a Partner in KPMG UK's healthcare and life sciences strategy team, based in London. Anna has held consulting and leadership roles at KPMG, Prophet, and Xerox, specializing in commercialization and growth strategy for pharmaceuticals and diagnostics. She started her career at Bayer Diagnostics (now Siemens) in product development and commercial. She holds an MBA from London Business School and a B.A. in Chemistry & French from Oberlin College.